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Summary
During intestinal transplant (ITx) operation, intestinal lymphatics are not 
reconstituted. Consequently, trafficking immune cells drain freely into the 
abdominal cavity. Our aim was to evaluate whether leucocytes migrating 
from a transplanted intestine could be recovered from the abdominal drain­
ing fluid collected by a peritoneal drainage system in the early post-ITx 
period, and to determine potential applications of the assessment of drain­
ing cellular populations. The cell composition of the abdominal draining 
fluid was analysed during the first 11 post-ITx days. Using flow cytometry, 
immune cells from blood and draining fluid samples obtained the same day 
showed an almost complete lymphopenia in peripheral blood, whereas 
CD3+CD4+CD8, CD3+CD4 CD8+ and human leucocyte antigen D-related 
(HLA-DR)+CD19+ lymphocytes were the main populations in the draining 
fluid. Non-complicated recipients evolved from a mixed leucocyte pattern 
including granulocytes, monocytes and lymphocytes to an exclusively lym­
phocytic pattern along the first post-ITx week. At days 1-2 post-Itx, analysis 
by short tandem repeats fingerprinting of CD3+CD8+ sorted T cells from 
draining fluid indicated that 50% of cells were from graft origin, whereas by 
day 11 post-ITx this proportion decreased to fewer than 1%. Our results 
show for the first time that the abdominal drainage fluid contains mainly 
immune cells trafficking from the implanted intestine, providing the oppor­
tunity to sample lymphocytes draining from the grafted organ along the 
post-ITx period. Therefore, this analysis may provide information useful for 
understanding ITx immunobiology and eventually could also be of interest 
for clinical management.
Keywords: abdominal cavity drainage, immune cells, intestinal transplant, 
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Introduction
Small bowel transplantation (Tx) has become an accepted 
clinical option to treat patients with intestinal failure and 
total parenteral nutrition (TPN) life-threatening com­
plications [1,2]. Availability of new immunosuppressant 
protocols and improvement in post-operative patient man­
agement have decreased mortality and graft loss, improving 
survival. In spite of this progress, acute cellular rejection 
remains as one of the major threats for intestinal transplant 
patients [3,4], especially in the early post-Tx period when 
reduction of immunosupression may be needed due to 
infectious or surgical complications. Post-Tx immunological 
events are common after intestinal transplant (ITx), as the 
small bowel harbours a high number of immune cell popu­
lations [5]. This increases the possibilities of undergoing 
allogenic or non-specific immune activation in the context 
of ITx leading to acute cellular rejection episodes, which 
have been described as occurring with high frequency during 
the follow-up of ITx patients [6,7].
At the end of the engraftment, ITx provides high accessi­
bility to biological material derived from the transplanted 
organ, giving a unique opportunity to monitor biological 
processes ongoing on the grafted organ directly or indirectly. 
The ileostomy provides direct access to the graft, being used 
routinely for histological follow-up for graft rejection detec­
tion, allowing sampling of intestinal content for clinical or 
research purposes. Furthermore, in the early post-transplant 
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period an abdominal drain is used for monitoring post­
operative abdominal bleeding or the presence of bile or 
intestinal content in the peritoneal cavity.
During the surgical procedure for isolated ITx, blood cir­
culation can be restored using a vascular anastomosis to the 
mesenteric circulation or to the aorta and cava vein (sys­
temic circulation). However, the mesenteric lymphatic 
vessels are not reconstructed in any case. Under normal 
physiological conditions, mesenteric vessels collect the leu­
cocytes migrating out of the intestinal mucosa [5]. We 
hypothesized that cell analysis of the peritoneal cavity drain­
age allows the assessment of immune cells migrating directly 
out of the graft through the intestinal lymphatic vessels.
In the present report, we analysed the leucocyte popula­
tions present in the fluid collected by the abdominal drain 
left in the early post-operative period in a series of isolated 
ITx recipients. To our knowledge, there has been no previous 
report showing the feasibility, value and potential clinical 
benefits of performing this type of analysis in post-Tx clini­
cal practice. The data presented here indicate that this 
approach may provide a deeper insight into the biology of 
immune cells migrating out of the graft, improving our 
understanding of immune processes that take place in the 
early post-transplant period.
Materials and methods
Patients and case reports
One adult and five paediatric patients presenting short bowel 
syndrome (SBS) and lack of central venous accesses as indi­
cation underwent isolated ITx between December 2007 and 
November 2008 and were enrolled in this study.
Patient 1 was a 53-year-old male, with SBS secondary to 
intestinal ischaemia. Patient 2 (a 9-year-old boy), patient 3 (a 
4-year-old boy), patient 5 (a 9-year-old boy) and patient 6 (a 
6-year-old girl) presented SBS secondary to volvulae. Patient 
4 was a 3-year-old girl with SBS secondary to gastroschisis. 
Patients 2 and 4 were engrafted with portal drainage. No 
severe intra-operatory complications were observed. All 
patients received ABO-compatible grafts (1 mismatch O-A); 
all had cross-matches performed prospectively; only patient 
6 was transplanted with a positive B cell cross-match. The 
major clinical details, immunosuppressive treatment and 
major clinical events in the first 20 days post-ITx are sum­
marized in Table 1. Only patient 1 required an exploratory 
laparotomy due to post-endoscopic bleeding and question­
able perforation. The findings were negative for perforation 
and positive for peritonitis, but with negative cultures from 
the material obtained.
The study was approved by the Institutional Review Board 
of Favaloro Foundation. All six patients were informed and 
signed an agreement to participate in the study.
Collection of draining fluid
Isolated ITx can be performed using systemic or portal 
drainage; in both cases, the mesenteric lymphatic vessels are 
not reconstructed (Fig. la,i), leaving them draining freely 
into the peritoneal cavity after blood circulation is restored 
(Fig. la,ii). Before closing the abdominal wall, a silicon 
drainage that recovers fluid from the peritoneal cavity is 
placed close to the mesenteric border (Fig. 1 a,iii). The sam­
pling of draining fluid started from post-Tx day 0 and con­
tinued for 2-3 weeks, depending on the clinical condition. 
Draining fluid was aspirated into a closed receptacle, 
emptied when full, and the volume and quality of the liquid 
were recorded systematically. Samples for cell analysis were 
collected overnight (from midnight to 8 a.m.).
Cell count in different fluids
Whole blood and draining fluid cell counts were assessed 
with an automated cell counter (Cell-dyn 3200; Abbott Diag­
nostics, Abbott Park, IL, USA) every second day as part of the 
clinical follow-up.
Cell purification
Draining fluid samples were filtered through an 80-llm filter 
mesh (BD Biosciences, San Jose, CA, USA) in 50 ml Falcon
Table 1. Detailed immunosupressive regimen and clinical complications in the early post-TX period.
Patient Age Diagnosis before ITx
Immunosupression
Complications after ITxDonor Induction Maintenance
1 53 SBS secondary to Thymoglobulin Anti-CD25 Tacrolimus, MMF, steroids Peritonitis, intestinal
intestinal ischemia bleeding
2 9 SBS secondary to volvulae Thymoglobulin Tacrolimus, MMF, steroids
3 4 SBS secondary to volvulae Thymoglobulin Anti-CD25 Tacrolimus, MMF, steroids
4 3 SBS secondary to gastroschisis Thymoglobulin Anti-CD25 Tacrolimus, MMF, steroids Peroral herpes lesions
5 9 SBS secondary to volvulae Thymoglobulin Anti-CD25 Tacrolimus, MMF, steroids
6 6 SBS secondary to volvulae Thymoglobulin Thymoglobulin Tacrolimus, MMF, steroids Pancreatitis, abdominal
collection
Itx: intestinal transplant; MMF: mycophenolate mofetil; SBS: short bowel syndrome.
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(i) (ii) (iii)
(a)
Superior mesenteric artery close abdominal drain
Superior mesenteric vein
• ■ ► Root of the mesentery
Fig. 1. Analysis of draining fluid after isolated 
intestinal transplant, (a) Graft after backtable 
surgery of isolated intestinal transplant (Itx). (i) 
The root of mesentery is dissected, isolating 
mesenteric artery and vein. The disruption of 
lymphatics in the root of mesentery allows cells 
flowing through the lymph to leak into the 
peritoneal cavity, (ii) Reconstitution of blood 
flow during implantation is shown. This allows 
normal blood flow to the graft and minimizes 
blood release into the peritoneal cavity. 
Lymphatic vessels dissected in the root of 
mesentery are not ligated, (iii) A schematic 
draw of the collection of draining fluid with a. 
Jackson-Pratt drainage system, (b) Volume of 
draining fluid collected daily shown as a 
box-plot indicating 25th and 75th percentiles, 
the mean and the standard deviation (s.d.) of 
values recorded for the six patients analysed, 
(c) Total number of leucocytes measured by 
automated cell counter in the draining fluid, 
represented in box-plot, as indicated in (b). (d) 
Comparative cell count measured by automated 
cell counter of neutrophils and lymphocytes 
between peripheral blood and draining fluid of 
a. single patient (patient 3) at different days 
post-ITx.
Days post-transplantDays post-transplant
Leucocyte count
Days post-transplant
tubes and centrifuged at 400 g for 10 min at 4°C. To lyse 
erythrocytes, the cell pellet was resuspended in an adequate 
volume of approximately 10 ml of ammonium chloride 
lysing solution (ACK) and incubated for 5 min at room 
temperature. Fifteen ml of phosphate-buffered saline (PBS) 
without Ca2+ and Mg2 containing 0-1% sodium azide and 
2% fetal bovine serum (FBS) (PAA, Pasching, Austria) [fluo­
rescence activated cell sorter (FACS) buffer] were added and 
mixed gently. The cell suspension was centrifuged at 300 g 
for 5 min. Supernatant was discarded and the cell pellet was 
washed with 5 ml of FACS buffer, centrifuged and resus­
pended in 1 ml of FACS buffer. Cells were counted using a 
counting chamber.
Flow cytometry
First, 0-5 x 106 cells/tube were incubated with inactivated 
human serum to block Fc receptors. Cells were then 
incubated with conjugated specific antibodies: anti-CD3 
(UCHT1), anti-CD4 (RPA-T4), anti-CD8 (RPA-T8; eBio­
science), anti-CD19 (HIB19) anti-CD56 (MEM-188), anti- 
CDllb (CBRM1/5), anti-CDllc, anti-CD14 (M5E2), anti- 
CD86 (FUN-1), anti-human leucocyte antigen D-related 
(HLA-DR) (G46-6) purchased from BD Biosciences for 
20 min at 4°C in the dark. Cells were washed and analysed 
with a BD FACSCalibur™ flow cytometer (BD Biosciences). 
Analysis was performed using CELLQuest™ (BD Bio­
sciences) and Flowjo (Tree Star Inc., Ashland, OR, USA) 
software.
Cell sorting
A total of 1 x 107 cells were stained with anti-CD3 and anti- 
CD8 antibodies for 30 min at 4°C in the dark. Cells were 
washed and the pellet was resuspended in 600 |11 FACS 
buffer. The sorting advice for the BD FACSCalibur™ flow 
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cytometer (BD Biosciences) was used. Exclusion mode was 
selected, CD3+CD8+ cells gated and 100 000 cells were sorted 
for genomic DNA purification.
Genomic DNA purification for analysis of percentage 
of donor versus recipient cells
Genomic DNA was purified from sorted cells by a DNA 
purification kit (Machery-Nagel, Duren, Germany). Short 
tandem repeat (STR) markers were amplified and analysed 
using PowerPlex* 16 System (Promega, Madison, WI, USA), 
using standard conditions following the manufacturer’s 
protocol. PCR amplification was performed using a Gene- 
Amp* PCR System 9700 (Applied Biosystems, Carlsbad, CA, 
USA). PCR products were analysed using an ABI PRISM* 
310 Genetic Analyzer (Applied Biosystems). Allele discrimi­
nation was performed using GeneMapper* ID version 3-2 
software. The percentage of cell population coming from 
donor or recipient was calculated as average number of the 
percentage of each single peak compared to individual recep­
tor and donor samples.
Correlation with clinical events
Patient records were analysed retrospectively, aiming to cor­
relate cell population analysis with the most relevant clinical 
events observed in each patient.
Results
Collection of abdominal draining fluid
The volume of abdominal fluid collected in each patient 
varied daily and we observed interpatient variability 
(Fig. lb). However, the general observed tendency is that 
fluid volume decreased during the post-operative period 
until the drain was removed. On average, during the first 3 
days post-ITx, 210 ± 43 ml of abdominal fluid were col­
lected, while the average of collected fluid from days 6-10 
was 78 ± 8 ml (Fig. lb). A sample of draining fluid was 
analysed daily to obtain differential counts of white blood 
cells (WBC). The number of red blood cells in the fluid 
allowed us to estimate blood contamination. Samples with 
more than 3 x 104 red cells/lll were discarded. Despite varia­
tions observed in each patient and on each post-operative 
day (Fig. lc and d), a significant number of leucocytes 
(2-7 ± 0-9 x 106 cells/ml) were recovered. When peripheral 
blood cellularity was compared to the cell count in the 
abdominal fluid, a different cellular composition was 
observed within the same patient/day (Fig. Id). Although 
lymphopenia (lymphocyte percentage 14 ± 9%, in all blood 
samples analysed) was observed in peripheral blood, lym­
phocytes constituted the most prevalent cells in draining 
fluids (66 ± 37%, in all peritoneal fluid samples analysed). 
This finding was seen repeatedly along the follow-up.
Analysis of cell populations in abdominal draining 
fluid
To address the question of which cell populations are 
present in the draining fluid, flow cytometry analysis was 
performed using a panel of specific antibodies against 
surface markers. Although the number of cells in the dif­
ferent gates and the FSC/SSC plot can vary during the post­
operative sampling period, two main patterns during the 
follow-up of patients without a clinical event could be 
defined (Fig. 2b). The pattern that includes cells present in 
Rl, R2 and R3 was observed commonly during the first 3 
days post-transplant (pattern 1, Fig. 2a). The pattern con­
stituted by lymphocytes (Rl) was detected mainly from 
post-Tx days 3-5 (pattern 2, Fig. 2b) until removal of the 
drainage. The main lymphocyte subsets detected in Rl for 
either patterns 1 or 2 were CD3+CD4+ T cells, CD3+CD8+ T 
cells and CD19+HLA-DR+ B cells (Fig. 2c and d). Further­
more, Rl contained, at a very low percentage (usually less 
than 2%), GL)3 GL)56 natural killer (NK) cells and 
CD3+CD56+ T cells (data not shown). When pattern 1 was 
observed, the main population (>80%) detected in R2 was 
positive for the specific monocyte/macrophage marker 
CD14 and for CDllc (Fig. 2e). This subset was character­
ized further as HLA-DRhlgh (Fig. 2f), CDllb10W (Fig. 2g) and 
CD86-positive (Fig. 2h), which might correspond to acti­
vated macrophages. The granulocytes (R3) were not char­
acterized further. It should be emphasized that different 
clinical events, such as infections or intestinal obstructions, 
could be accompanied by a modification in the pattern of 
draining cell populations detected by flow cytometry. We 
observed a reappearance of gates R2 and R3 in all patients 
(three cases) with clinical events (data not shown). 
However, more cases should be analysed to conclude 
definitively that a correlation exists between clinical find­
ings and changes in the abdominal fluid leucocyte count.
Progress of lymphocyte population over time
Analysis of the main lymphocyte populations along the early 
follow-up of each of the six patients reflects some general 
trends in the ongoing of the transplanted small bowel. As can 
be seen in Fig. 2i, despite some variability in the percentage 
of CD3+CD4+ and CD3+CD8+ T cells detected, both subsets 
remained as the major populations during the first 10 days 
post-ITx. B cells, defined as CL)3 CL)19 HLA-DR , tended to 
decrease in the first 2 days post-ITx from 30-50% to fewer 
than 10% of Rl. Individual variation in the percentage of the 
B cell population observed may reflect particular clinical 
situations.
Donor versus recipient contribution to the lymphocyte 
populations from collected fluid
As a proof-of-principle, we wanted to address the following 
questions: how much of the drained CD8+ T cells were still
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Fig. 2. Flow cytometry analysis of peritoneal 
draining fluid, (a) Typical forward-scatter (FSC) 
side-scatter (SSC) dot-plot pattern observed in 
the first 1-3 post-operative days. Lymphocyte 
gate (Rl, 60%), monocyte gate (R2, 6%) and 
granulocyte gate (R3, 2-3%) are indicated, (b) 
Dot-plot representation observed after days 3-5 
post-intestinal transplant (Itx), containing 
mainly cells in the lymphocyte gate (Rl, 80%), 
whereas no clear populations are detected in R2 
(1%) and R3 (0-2%). In both plots, 50 000 cells 
were acquired. Analysis of the lymphocyte gate 
showing mainly CD3+CD4+ or CD3+CD4~ T cell 
populations (c). This latter population was 
mainly CD3+CD8+, as detected by independent 
staining (not shown). CD19+ human leucocyte 
antigen D-related (HLA-DR)+ B cell population 
(d). Cells in the monocyte gate are positive for 
CDllc and CD14 (e). Histograms for the 
analysis of HLA-DR (f), CDllb (g) and CD86 
(h) on the CD14+ CDllc+ gate are depicted. 
Isotype controls are included in each histogram. 
Data analysis shown corresponds to two 
draining samples of the same patient. Flow 
cytometric analyses were conducted on samples 
from all patients, (i) Analysis of lymphocyte 
subsets over time by flow cytometry. Relative 
percentages of CD4+ T cells, CD8+ T cells and 
CD19+ B cells are shown as a. box-plot and the 
mean as symbol. Time of follow-up ranges 
from days 1 to 10 post-ITx.
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from the donor; at which day did the recipients’ lymphocytes 
appear in the fluid; and how their relative proportion varied 
along the post-operative period analysed.
To answer these questions, we used a genetic fingerprint 
analysis to identify the genetic pattern of the donor and 
the recipient in the genomic DNA obtained from the cell 
populations isolated by cell sorting. The methodology 
employed was based on the amplification of 16 different 
STR regions that are highly polymorphic in the human 
genome. According to the amount of amplified material for 
each marker, in the case of mixed populations it is possible 
to estimate the percentage of material belonging to the 
different alleles. CD3+CD8+ T cells from patients 3, 5 and 6 
were sorted at days 1, 2, 7 and 11 post-transplant. 
One hundred thousand CD8+ T cells were sorted from a 
total of 1 x 107 mononuclear cells. A preoperative periph­
eral blood sample from the recipient and a blood sample 
from the donor were used as reference of individual finger­
print. We observed a progressive decrease in the number of 
CD8+ donor T cells along the first post-operative week 
(Fig. 3). Dispersion in the donor/recipient ratio during the 
first 48 h post-ITx was due to early diminution of donor 
cells in patient 5. At later time-points, cells from the recipi­
ents become the only type of cells that can be recovered.
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Days post-tran spiani
■ Donor cells
■ Recipient cells
Fig. 3. Percentage of donor versus recipient CD8+ T lymphocyte 
population in draining fluid along the early post operative period. 
CI)3CI)8CI)1 cells were sorted using the ‘single cell’ sort mode of 
BD FACSCalibur™ flow cytometer with sorting option. Purity was 
reassessed by fluorescence activated cell sorter (FACS) analysis in pilot 
experiments showing at least 95% of the desired population. Genomic 
DNA was prepared from CD8+-sorted T cells and short tandem 
repeats (STR) were amplified by polymerase chain reaction (PCR) 
using a commercial kit. Allele discrimination in each case allows 
establishment of the ratio of donor/recipient cells in each sample. 
Mean and standard deviation from patients 3, 5 and 6 are depicted.
This result indicates that in the early post-operative period 
the recipient cell population replaces the circulating donor 
CD8+ T cell population.
Discussion
Peritoneal fluid analysis has been accepted as a diagnostic 
tool to detect peritonitis, malignancies, portal hypertension, 
cardiac failure, tuberculosis, pancreatic or kidney disease [8]. 
There are guidelines for ascitic fluid analysis in cirrhotic 
patients with ascitis and bacterial peritonitis [9,10], but there 
are no specific guidelines for the analysis of abdominal fluid 
draining throughout the drains placed during surgery. Since 
the original descriptions of ITx, fluid collected from 
abdominal drainages has been used for clinical/surgical 
assessment, as has been performed for other organ trans­
plants or general surgery, aiming to observe the presence of 
blood, bile, enteric or chylous content in the peritoneal 
cavity. The results presented here indicate that fluid collected 
from abdominal draining can also be used to analyse the 
presence, variations and graft/donor origin of immune cells 
migrating directly from the graft, opening a new dimension 
among the possibilities of post-ITx monitoring.
The process of restitution of the lymphatic network after 
ITx in humans has not been analysed. In animal models, it 
has been shown that lymphatic reconstitution begins within 
2 weeks after ITx and is completed approximately 6 weeks 
after ITx [11,12]. In patients it is assumed that it might take 
a similar course, mainly by forming neo-lymphatic collater­
als around the vascular anastomosis [13]. Along the imme­
diate post-operative period, the daily volume of drained 
abdominal fluid decreases. This might be due partially to the 
neo-formation of lymphatic vessels. The amount of abdomi­
nal fluid recovered is dependent upon many aspects of 
patient care, such as fluid-electrolyte management, degree of 
dissection needed during the surgical procedure and intro­
duction of enteral nutrition, among other factors. These 
aspects are reflected in the great dispersion of daily fluid 
volume obtained from one patient to another. Comparing 
the volume of draining fluid from 17 patients with isolated 
ITx and two patients who underwent combined liver­
intestine Tx, the two combined Tx patients showed a seven­
fold reduced volume of fluid. The lower volume collected in 
combined liver-intestinal transplant might be due to the lack 
of transection or dissection of the mesentery root, whereas 
the organ procurement for the isolated ITx the mesentery 
root is usually dissected (Fig. la). This observation under­
lines the finding that the intestinal lymphatic vessels leak 
into the peritoneal cavity, where the fluid is collected by 
Jackson-Pratt silicon drainage.
The lack of a correlation between the leucocyte population 
count in peripheral blood and the cellularity observed in the 
abdominal fluid (Fig. Id) (usually much richer in lympho­
cytes) may indicate that the main cellular source of the drain­
ing fluid is disrupted lymph vessels that contain the outflow of 
leucocytes from the graft. Although information on cell 
populations present in human intestinal lymph is scarce, 
several animal studies have been performed to characterize 
different aspects of leucocytes migrating from intestinal 
mucosa. Most of the animal models are based on the cannu­
lation of either afferent mesentery lymphatic vessels or the 
thoracic duct after surgical removal of mesenteric lymph 
nodes. These studies have shown that lymphocytes constitute 
the main population in the mesenteric lymph [14]. Further­
more, T lymphocytes are the predominant population, with a 
comparable amount of CD8+ and CD4+ cells, whereas B cells 
represent a minor component of the lymphoid populations 
[15-17]. Several studies have focused upon the characteriza­
tion of dendritic cells migrating from the intestine [18,19], 
CDllb+CDllc+ CD103+ being the major population [19,20]. 
Using FACS analysis we have observed an initial pattern with 
the presence of granulocytes, lymphocytes and monocytes 
during the first 3 days post-ITx. The strong presence of granu­
locytes might be associated with the immediate post-surgical 
inflammatory response in a procedure that involved opening 
of the intestinal lumen. In subsequent days, a shift towards a 
lymphocytic pattern was observed. Although we have analy­
sed a restricted series of patients with different ages, immu­
nosuppressive treatments and clinical outcomes, the CD4+ or 
CD8+ T cell counts were similar during the period analysed,
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being the major population retrieved, which is in agreement 
with the above-mentioned reports on animal models. When 
no clinical events were indicative of any inflammatory pro­
cesses, we detected a decrease in both the B cell population 
and granulocytes during the post-operative period analysed. 
Conversely, monocytes and granulocytes increased markedly 
in the fluid of patients showing clinical events (data not 
shown). In certain cases, the changes in the cell composition 
of the draining fluid preceded the clinical events or changes in 
histology, indicating a potential use of this analysis as part of 
the clinical follow-up of the patient during the early post­
transplant period.
We have also shown, by analysis of STR on DNA from 
sorted CD8+ T cells, that it is possible to establish the relative 
contribution from donor or recipient to this population. We 
found that on post-operative day 2, 50% of the CD8+ drain­
ing T cells already belong to the recipient, and by the 11th 
day almost all draining cells have been replaced by recipient 
cells. These results are in agreement with data reported by 
Wang et al. [21], who were using a mouse heterotopic ITx 
model showing that CD4+ and CD8 donor T cells represent 
50% of the total population in graft secondary lymphoid 
organs 1 day after Itx, and their proportion decreases to 
fewer than 2% at day 5 post-ITx.
Our results show for the first time the possibility of anal­
ysing lymphocyte trafficking from the graft in a human 
intestinal transplant. Further studies should be carried out 
to analyse whether the dynamic of replacement of other 
cell populations, such as CD4+ T cells, CD19+ B cells, NK 
cells, macrophages and dendritic cells takes place. The 
mean residence time of each population within the intes­
tinal mucosa at this site may influence the dynamic of this 
trafficking, and also on the capacity to proliferate [22]. The 
discrimination of cell populations from the donor or 
recipient present in the abdominal fluid may allow estima­
tion the half-life of different cell subsets within the intesti­
nal mucosa, and also assessment of the kinetics of de novo 
colonization of different mononuclear lineages. Conversely, 
analysis of the donor-recipient origin of draining lympho­
cytes may have a direct impact in detection of the expan­
sion of graft populations, leading potentially to graft- 
versns-host disease.
The first encounters of the recipient lymphoid cells with 
the donor cells take place during the early post-operative 
period [23]. As shown in an ITx animal model, priming of 
recipient T cells takes place mainly in graft secondary lym­
phoid organs early after transplant [21], suggesting that the 
monitoring activation markers on graft-draining lympho­
cytes could be a critical parameter to determine the risk of 
rejection.
Although not reported here, the fluid can also be used for 
evaluation of soluble factors, such as cytokines. Taking into 
account that mesenteric lymphatics are important contribu­
tors to the peritoneal cavity drainage, several determinations 
could be envisaged to monitor different important aspects of 
ITx such as bacterial translocation, enteral drug absorption 
or enteral metabolite profile. Furthermore, with a sufficient 
number of cases analysed, it would be possible to set up 
analytical parameters for expected normal evolution, and 
this information could be used for clinical follow-up and 
management.
In summary, we consider that the analysis of the abdomi­
nal draining fluid after intestinal transplant provides an 
innovative approach that can generate valuable information 
on the immunobiology of the intestinal graft, and could 
potentially become a useful tool in the patient care. Draining 
fluid analysis offers a unique opportunity to monitor the 
graft status and a direct method to analyse the biology of 
immune cells migrating outside the graft, improving our 
understanding on immune processes that take place in the 
early post-transplant period. Further analyses are necessary 
to define cellular patterns that could be associated with early 
rejection events or infections.
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